Human Health vs Aidy for Crohn's: Symptom Scope or IBD Depth?

Human Health's listing covers flexible records; Aidy gives Crohn's users structure for daily care needs. Human Health's listing claims symptoms, conditions, treatments, and profiles. Aidy connects bowel changes with food, biologic schedules, disease activity, and clinician reports.

Quick answer: For most people with diagnosed Crohn's, choose Aidy for free IBD structure, biologic tools, modified HBI trends, and reports. Human Health is the genuine exception for people needing its advertised multi-condition tracking, Android access, broad records, or dependent profiles.

Decision factor	Aidy	Human Health (public claims)
Best for	Crohn's symptom app	Claims broad family records
Daily IBD record	Stool, food, symptoms, treatment	Claims symptoms, treatments, records, profiles
Treatment tools	Detailed biologic schedules	Claims flexible treatment tracking
Reports and insights	Modified HBI and reports	Claims insights and paid reports
Access and cost	Free	Claims free tier plus HumanPlus
Overall pick	Aidy	Breadth exception

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

Human Health’s symptom and family scope is unusually broad

The current Human Health App Store listing advertises 2,000-plus symptoms and treatments spanning medicines, supplements, therapies, and lifestyle changes. It says entries may include notes or photos and claims one timeline for diagnoses, tests, journal entries, history, symptoms, and treatments, with trends and PDF reports. That scope makes Human Health a strong chronic illness tracker for family use and for someone still assembling a diagnosis.

Human claims multiple profiles are available to free and HumanPlus users. Its profile documentation says an account holder can track a child, partner, or other dependent and switch profiles inside one account. The same documentation says another carer or clinician cannot manage that profile from a separate device. The feature works best when one person keeps the records. Aidy focuses on an individual with Crohn’s disease or ulcerative colitis; dependent profiles are outside its current scope.

Crohn’s depth favors a purpose-built record

Crohn’s can involve diarrhea, abdominal pain, weight loss, fatigue, fever, nausea, joint symptoms, and skin or eye changes. That variety explains Human Health’s appeal. A peer-reviewed project developing a Crohn’s patient-reported diary also identified abdominal pain, stool frequency, very soft or liquid stools, rectal bleeding, urgency, nausea, vomiting, incontinence, and general wellbeing as relevant daily fields.

Human Health says users can select condition-relevant symptoms and record impact, time, notes, and photos. Its current condition guide explains that diagnoses remain independent from symptoms and treatments. That choice suits overlapping conditions, although a person must construct the Crohn’s story from separate records.

Aidy supplies an IBD-first structure with common and custom symptom severity, Bristol stool entries, meals, medication adherence, and modified Harvey-Bradshaw Index trends for Crohn’s. Its biologic workflow includes configurable schedules, dose reminders, injection-site rotation, post-dose check-ins, and route or interval changes. Aidy also provides food-symptom correlations. Those are personal observations and do not prove causation because NIDDK says specific foods have not been shown to cause or worsen Crohn’s symptoms, although clinicians may suggest food diaries to identify individual patterns.

Reports still need clinical context

Human Health says its free tier includes unlimited symptoms, conditions, treatments, medical history, Insights, adherence views, and basic health summaries. It claims HumanPlus adds unlimited file storage, customizable reports, unlimited pattern history, and advanced correlations. Aidy creates doctor-ready reports that combine symptoms, stool patterns, food, medication adherence, and self-reported disease-activity trends. Human Health is stronger for a wide longitudinal record; Aidy creates the more focused gastroenterology summary.

Neither report establishes whether intestinal inflammation is active, and the American Gastroenterological Association recommends combining symptoms with biomarkers for Crohn’s monitoring. NIDDK says blood tests, stool tests, endoscopy, and imaging may contribute to Crohn’s assessment. A Cochrane review found that web-based IBD monitoring probably has similar adult symptom, flare, and quality-of-life outcomes to usual care, with a possible small medication-adherence benefit. App reports are supporting records for that wider care process.

Free tiers, platforms, and privacy require a close read

Human says its free version includes unlimited tracking, reminders, insights, and pattern detection, while HumanPlus supplies expanded storage and reports. Human’s support page confirms monthly and annual subscriptions, but Apple’s current catalog lists six identically named purchases from $4.99 to $54.99 without terms, leaving the HumanPlus price unclear. Human's site claims worldwide English-language iOS and Android access.

Human’s privacy policy says anonymized or aggregated health data may be used for product development and research. Personally identifiable health data requires specific informed consent for research studies. The policy also covers access, erasure, and portability rights. Users managing a dependent’s record should review those controls with the same care they apply to their own data.

Aidy is free, has no paid user subscriptions or ads, and can be accessed through text messaging. The free access covers its complete Crohn's treatment and reporting workflow. Human Health is the better fit for broad symptom discovery, Android access, and one-person management of dependent profiles. Aidy is the stronger Human Health alternative for bowel detail, food context, biologic organization, adherence, disease-activity trends, and gastroenterology reports.